<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05070234</url>
  </required_header>
  <id_info>
    <org_study_id>GenSci-GH-21016</org_study_id>
    <nct_id>NCT05070234</nct_id>
  </id_info>
  <brief_title>Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature</brief_title>
  <official_title>Genetic Diagnosis and the Response to Recombinant Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chunxiu Gong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Children's Hospital of Zhejiang University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chengdu Women's and Children's Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Second University Hospital, Sichuan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>GeneScience Pharmaceuticals Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multi-center, retrospective and non-interventional research. In this study, a&#xD;
      total of 150 short children who were small for gestational age and had been treated with&#xD;
      recombinant human growth hormone (rhGH) are selected for genetic testing. The aims of this&#xD;
      study are to analyze the genetic etiology of SGA children with short stature, and to compare&#xD;
      the efficacy and safety of rhGH treatment in subjects with different etiologies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 11, 2021</start_date>
  <completion_date type="Anticipated">August 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genetic testing</measure>
    <time_frame>At baseline</time_frame>
    <description>To detect the disease-causing genes of SGA children with short stature</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Small for Gestational Age Infant</condition>
  <condition>Silver-Russell Syndrome</condition>
  <condition>Genetic Diseases, Inborn</condition>
  <arm_group>
    <arm_group_label>short stature children born small for gestational age</arm_group_label>
    <description>This group was defined as a group of children whose birth weight and/or birth length equal or less than -2 SD for sex and gestational age, and who had failed to catch up in growth, remaining short after 2 years old.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Blood collection for genetic analysis</intervention_name>
    <description>Genetic tests in this study are sequential testing, including MS-MLPA, whole exome sequencing, whole genome sequencing, as well as RNA-seq.</description>
    <arm_group_label>short stature children born small for gestational age</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children's hospical&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Single birth, clinical diagnosis of SGA;&#xD;
&#xD;
          2. rhGH treatment beginned before puberty (Tanner stage I), regardless of gender;&#xD;
&#xD;
          3. Before starting rhGH treatment, height was lower than -2 SDS compared with normal&#xD;
             children of the same age and sex;&#xD;
&#xD;
          4. All the subjects and their guardians signed the informed consent and the informed&#xD;
             consent for genetic testing.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. No efficacy and safety data were recorded after treatment with rhGH;&#xD;
&#xD;
          2. A history of blood transfusion within 3 months before the collection of the genetic&#xD;
             blood samples, or a history of bone marrow transplantation between rhGH treatment and&#xD;
             the enrollment in this study;&#xD;
&#xD;
          3. Other conditions that the investigator considered unsuitable for inclusion in this&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chunxiu Gong, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bingyan Cao, doctor</last_name>
    <phone>13811748954</phone>
    <email>caoby1982@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiajia Chen, doctor</last_name>
    <phone>13810773718</phone>
    <email>chenjiaj2009@126.com</email>
  </overall_contact_backup>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 27, 2021</study_first_submitted>
  <study_first_submitted_qc>September 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 7, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Children's Hospital</investigator_affiliation>
    <investigator_full_name>Chunxiu Gong</investigator_full_name>
    <investigator_title>Department of Endocrinology, Genetics and Metabolism</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dwarfism</mesh_term>
    <mesh_term>Silver-Russell Syndrome</mesh_term>
    <mesh_term>Genetic Diseases, Inborn</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

